Fibrillatory rate response to candesartan in persistent atrial fibrillation

Europace

Volumn 10, Issue 10, 2008, Pages 1138-1144

  Bollmann, Andreas ^a,b   Tveit, Arnljot ^c   Husser, Daniela ^a,b   Stridh, Martin ^a   Sörnmo, Leif ^a   Smith, Pål ^c   Olsson, S Bertil ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^c VESTRE VIKEN HOSPITAL TRUST   (Norway)

Author keywords

Angiotensin receptor blockade; Atrial fibrillation; Cardioversion; ECG; Remodelling

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; DIGITOXIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; VERAPAMIL; WARFARIN;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; TREATMENT OUTCOME;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; TETRAZOLES; TREATMENT OUTCOME;

EID: 52949129423     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun195     Document Type: Article

References (36)

1. Anand K, Mooss AN, Hee TT, Mohiuddin SM. Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation. Am Heart J 2006;152:217-22.
2. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005;45:1832-9.
3. Ueng KC, Tsai TP, Yu WC, Tsai CF, Lin MC, Chan KC et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. Eur Heart J 2003;24:2090-8.
4. Madrid AH, Bueno MG, Rebollo JM, Marin I, Pena G, Bernal E et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 2002;106:331-6.
5. Tveit A, Grundvold I, Olufsen M, Seljeflot I, Abdelnoor M, Arnesen H et al. Candesartan in the prevention of relapsing atrial fibrillation. Int J Cardiol 2007;120:85-91.
6. Li D, Shinagawa K, Pang L, Leung TK, Cardin S, Wang Z et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001;104:2608-14.
7. Shi Y, Li D, Tardif JC, Nattel S. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res 2002;54:456-61.
8. Caballero R, Delpon E, Valenzuela C, Longobardo M, Gonzalez T, Tamargo J. Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization. Mol Pharmacol 2001;59:825-36.
9. Zankov DP, Omatsu-Kanbe M, Isono T, Toyoda F, Ding WG, Matsuura H et al. Angiotensin II potentiates the slow component of delayed rectifier K+ current via the AT1 receptor in guinea pig atrial myocytes. Circulation 2006;113:1278-86.
10. Kistler PM, Davidson NC, Sanders P, Fynn SP, Stevenson IH, Spence SJ et al. Absence of acute effects of angiotensin II on atrial electrophysiology in humans. J Am Coll Cardiol 2005;45:154-6.
11. Capucci A, Biffi M, Boriani G, Ravelli F, Nollo G, Sabbatani P et al. Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation 1995;92:1193-202.
12. Husser D, Stridh M, Cannom DS, Bhandari AK, Girsky MJ, Kang S et al. Validation and clinical application of time-frequency analysis of atrial fibrillation electrocardiograms. J Cardiovasc Electrophysiol 2007;18:41-6.
13. Bollmann A, Husser D, Mainardi L, Lombardi F, Langley P, Murray A et al. Analysis of surface electrocardiograms in atrial fibrillation: techniques, research, and clinical applications. Europace 2006;8:911-26.
14. Bollmann A, Mende M, Neugebauer A, Pfeiffer D. Atrial fibrillatory frequency predicts atrial defibrillation threshold and early arrhythmia recurrence in patients undergoing internal cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol 2002;25:1179-84.
15. Bollmann A, Husser D, Steinert R, Stridh M, Sörnmo L, Olsson SB et al. Echo- and electrocardiographic predictors for atrial fibrillation recurrence following cardioversion. J Cardiovasc Electrophysiol 2003;14:S162-5.
16. Holmqvist F, Stridh M, Waktare JE, Sörnmo L, Olsson SB, Meurling CJ. Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation. Eur Heart J 2006;27:2201-7.
17. Stridh M, Sörnmo L, Meurling CJ, Olsson SB. Characterization of atrial fibrillation using the surface ECG: time-dependent spectral properties. IEEE Trans Biomed Eng 2001;48:19-27.
18. Stridh M, Sörnmo L. Spatiotemporal QRST cancellation techniques for analysis of atrial fibrillation. IEEE Trans Biomed Eng 2001;48:105-11.
19. Stridh M, Bollmann A, Olsson SB, Sörnmo L. Time-frequency analysis of atrial tachyarrhythmias: detection and feature extraction. IEEE Eng Med Biol Mag 2006;25:31-9.
20. Bollmann A, Husser D, Stridh M, Sörnmo L, Hindricks G, Roden DM et al. A genotype dependent intermediate ECG phenotype in patients with persistent lone atrial fibrillation (abstract). Circulation 2007;116:II:477.
21. Xi Q, Sahakian AV, Frohlich TG, Ng J, Swiryn S. Relationship between pattern of occurrence of atrial fibrillation and surface electrocardiographic fibrillatory wave characteristics. Heart Rhythm 2004;1:656-63.
22. Bollmann A, Husser D, Stridh M, Holmqvist F, Roijer A, Meurling CJ et al. Atrial fibrillatory rate and risk of left atrial thrombus in atrial fibrillation. Europace 2007;9:621-6.
23. Husser D, Cannom DS, Bhandari AK, Stridh M, Sörnmo L, Olsson SB et al. Electrocardiographic characteristics of fibrillatory waves in new-onset atrial fibrillation. Europace 2007;9:638-42.
24. Sakabe K, Fukuda N, Soeki T, Shinohara H, Tamura Y, Wakatsuki T et al. Relation of age and sex to atrial electrophysiological properties in patients with no history of atrial fibrillation. Pacing Clin Electrophysiol 2003;26:1238-44.
25. Chen YJ, Lee SH, Hsieh MH, Hsiao CJ, Yu WC, Chiou CW et al. Effects of 17beta-estradiol on tachycardia-induced changes of atrial refractoriness and cisapride-induced ventricular arrhythmia. J Cardiovasc Electrophysiol 1999;10:587-98.
26. Shinagawa K, Li D, Leung TK, Nattel S. Consequences of atrial tachycardia-induced remodeling depend on the preexisting atrial substrate. Circulation 2002;105:251-7.
27. Meurling CJ, Ingemansson MP, Roijer A, Carlson J, Lindholm CJ, Smideberg B et al. Attenuation of electrical remodelling in chronic atrial fibrillation following oral treatment with verapamil. Europace 1999;1:234-41.
28. Bollmann A, Sonne K, Esperer HD, Toepffer I, Klein HU. Patients with persistent atrial fibrillation taking oral verapamil exhibit a lower atrial frequency on the ECG. Ann Noninvasive Electrocardiol 2002;7:92-7.
29. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-68.
30. Kumagai K, Nakashima H, Urata H, Gondo N, Arakawa K, Seiko K. Effect of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol 2003;41:2197- 204.
31. Tai CT, Chen SA, Liu AS, Yu WC, Ding YA, Chang MS et al. Spectral analysis of chronic atrial fibrillation and its relation to minimal defibrillation energy. Pacing Clin Electrophysiol 2002;25:1747-51.
32. Everett TH IV, Moorman JR, Kok LC, Akar JG, Haines DE. Assessment of global atrial fibrillation organization to optimize timing of atrial defibrillation. Circulation 2001;103:2857-61.
33. Sra J, Biehl M, Blanck Z, Dhala A, Jazayeri MR, Deshpande S et al. Spontaneous reinitiation of atrial fibrillation following transvenous atrial defibrillation. Pacing Clin Electrophysiol 1998;21:1105-10.
34. Timmermans C, Rodriguez LM, Smeets JL, Wellens HJ. Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J Cardiovasc Electrophysiol 1998;9:122-8.
35. Smeets JL, Allessie MA, Lammers WJ, Bonke FI, Hollen J. The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium. The role of heart rate, autonomic transmitters, temperature, and potassium. Circ Res 1986;58:96-108.
36. Everett TH IV, Li H, Mangrum JM, McRury ID, Mitchell MA, Redick JA et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation 2000;102:1454-60.